Literature DB >> 35076738

Peptidoglycan-based immunomodulation.

Qingshen Sun1,2, Xiaoli Liu1,2, Xiuliang Li3,4.   

Abstract

Peptidoglycan (PGN) is a unique component in the cytoderm of prokaryotes which can be recognized by different pathogen-associated molecular patterns (PAMPs) in eukaryotes, followed by a cascade of immune responses via different pathways. This review outlined the basic structure of PGN, its immunologic functions. The immunomodulation pathways mediated by PGN were elaborated. PGN induces specific immunity through stimulating different cytokine release and Th1/Th2-dominated immune responses during humoral/cellular immune response. The nonspecific immunity activation by PGN involves immunomodulation by different pattern recognition receptors (PRRs) including PGN recognition proteins (PGRPs), nucleotide oligomerization domain (NOD)-like receptors (NLRs), Toll-like receptors (TLRs), and C-type lectin receptors (CLRs). The sources and classification of PGRPs were summarized. In view of the stimulating activities of PGN and its monomers, the potential application of PGN as vaccine or adjuvant was prospected. This review provides systematic information on PGN functionalities from the point of immunoregulation, which might be useful in the deep exploitation of PGN.Key points. The immunological functions of PGN were illustrated. Cellular and humoral immunomodulation by PGN were outlined. The use of PGN as vaccine or adjuvant was prospected.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Adjuvant; Immunomodulatory activity; PGN; Pattern recognition receptor

Mesh:

Substances:

Year:  2022        PMID: 35076738     DOI: 10.1007/s00253-022-11795-4

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  57 in total

Review 1.  Peptidoglycan recognition proteins (PGRPs).

Authors:  Roman Dziarski
Journal:  Mol Immunol       Date:  2004-02       Impact factor: 4.407

2.  Peptidoglycan and peptidoglycan-specific Th1 cells in psoriatic skin lesions.

Authors:  B S Baker; J D Laman; A Powles; L van der Fits; J S A Voerman; M-J Melief; L Fry
Journal:  J Pathol       Date:  2006-06       Impact factor: 7.996

3.  Liposome fusogenicity and entrapment efficiency of antigen determine the Th1/Th2 bias of antigen-specific immune response.

Authors:  Marija Brgles; Lidija Habjanec; Beata Halassy; Jelka Tomasić
Journal:  Vaccine       Date:  2009-07-24       Impact factor: 3.641

Review 4.  Mammalian PGRPs: novel antibacterial proteins.

Authors:  Roman Dziarski; Dipika Gupta
Journal:  Cell Microbiol       Date:  2006-07       Impact factor: 3.715

Review 5.  NOD1 and NOD2: signaling, host defense, and inflammatory disease.

Authors:  Roberta Caruso; Neil Warner; Naohiro Inohara; Gabriel Núñez
Journal:  Immunity       Date:  2014-12-06       Impact factor: 31.745

6.  Peptide mimics of peptidoglycan are vaccine candidates and protect mice from infection with Staphylococcus aureus.

Authors:  Yiguo Chen; Beiyi Liu; Daqing Yang; Xueli Li; Liyan Wen; Ping Zhu; Ning Fu
Journal:  J Med Microbiol       Date:  2011-03-24       Impact factor: 2.472

7.  Staphylococcus aureus peptidoglycan promotes osteoclastogenesis via TLR2-mediated activation of the NF-κB/NFATc1 signaling pathway.

Authors:  Faqi Cao; Wu Zhou; Guohui Liu; Tian Xia; Mengfei Liu; Bobin Mi; Yi Liu
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

8.  Cell-wall preparation containing poly-γ-D-glutamate covalently linked to peptidoglycan, a straightforward extractable molecule, protects mice against experimental anthrax infection.

Authors:  Thomas Candela; Fabien Dumetz; Evelyne Tosi-Couture; Michèle Mock; Pierre L Goossens; Agnès Fouet
Journal:  Vaccine       Date:  2012-11-01       Impact factor: 3.641

9.  A short-type peptidoglycan recognition protein from the silkworm: expression, characterization and involvement in the prophenoloxidase activation pathway.

Authors:  Kangkang Chen; Chen Liu; Yan He; Haobo Jiang; Zhiqiang Lu
Journal:  Dev Comp Immunol       Date:  2014-02-06       Impact factor: 3.605

10.  Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity.

Authors:  Thomas B Clarke; Kimberly M Davis; Elena S Lysenko; Alice Y Zhou; Yimin Yu; Jeffrey N Weiser
Journal:  Nat Med       Date:  2010-01-17       Impact factor: 53.440

View more
  1 in total

Review 1.  Through the Looking-Glass: Psychoneuroimmunology and the Microbiome-Gut-Brain Axis in the Modern Antiretroviral Therapy Era.

Authors:  Adam W Carrico; Emily M Cherenack; Leah H Rubin; Roger McIntosh; Delaram Ghanooni; Jennifer V Chavez; Nichole R Klatt; Robert H Paul
Journal:  Psychosom Med       Date:  2022-08-28       Impact factor: 3.864

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.